Divi's Laboratories Q2 net profit up 46% at Rs 520 crore

The company had posted a net profit of Rs 356.78 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to BSE.

November 07, 2020 / 04:32 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Divi's Laboratories on Saturday reported a 45.63 percent rise in its consolidated net profit at Rs 519.59 crore for the quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit of Rs 356.78 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to BSE.

Consolidated total income of the company stood at Rs 1,762.94 crore for the quarter under consideration. It was Rs 1,492.60 crore for the same period a year ago, it added.

The company had near normal operations during the quarter, the filing said.

"We have capitalised assets of Rs 615 crore during the quarter and the total capitalisation done during the half-year amounted to Rs 830 crore. We expect to complete the ongoing capex programs by the end of the financial year," it added.

Close
Apart from the existing capex programs, the company is taking up a new capex for an aggregate amount of Rs 400 crore for meeting new business opportunities in the custom synthesis projects, it added.
PTI
first published: Nov 7, 2020 04:31 pm

stay updated

Get Daily News on your Browser
Sections